HIV infection and sputum-culture conversion in patients diagnosed with Mycobacterium tuberculosis: A population-based study

Wiener Klinische Wochenschrift

Volumn 115, Issue 10, 2003, Pages 340-346

  Aliyu, Muktar H ^a   Salihu, Hamisu M ^a   Ratard, Raoul ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

HIV; Pulmonary; Sputum; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT MONITORING; POPULATION RESEARCH; RETROSPECTIVE STUDY; SPUTUM CULTURE; TREATMENT OUTCOME; UNITED STATES;

EID: 0038540298     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03041486     Document Type: Article

References (42)

1. Raviglione MC, Dixie SE, Kochi A (1995) Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226
2. Centers for Disease Control and Prevention (1989) A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 38: 269-272
3. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM (1994) Epidemiology of tuberculosis in the United States. JAMA 272: 535-539
4. Chaulk CP, Moore-Rice K, Rizzo RN, Caisson MD (1995) Eleven years of community-based directly observed therapy for tuberculosis. JAMA 274: 945-951
5. Small PM, Hopewell PC, Singh SP, et al (1994) The Epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 330: 1703-1709
6. Brudney K, Dobkin J (1991) Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 144: 745-749
7. Alland D, Kalkut GE, Moss AR, et al (1994) Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 330: 1710-1716
8. Barnes PF, Yang Z, Preston-Martin S, et al (1997) Patterns of tuberculosis transmission in central Los Angeles. JAMA 278: 1159-1163
9. Hopewell PC (1992) Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis 15: 540-547
10. Brindle R, Nunn PP, Githui W, Allen BW, et al (1993) Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis 147: 958-961
11. Chaisson RE, Clermont HC, Holt EA, et al (1996) Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV-infection. Am J Respir Crit Care Med 154: 1034-1038
12. Perriëns JH, St Louis ME, Mukadi YB, et al (1995) Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. N Engl J Med 332: 779-784
13. Pulido F, Pena J-M, Rubio R, et al (1997) Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. Arch Intern Med 157: 227-232
14. Middlebrook G, Reggiardo Z, Tigert WD (1977) Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis 115: 1066-1071
15. Klein N, Duncanson F, Lenox T, Pitta A, Cohen S, Wormser G (1989) Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 95: 190-102
16. Markowitz N, Hansen NI, Hopewell PC, et al (1997) Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med 126: 123-132
17. Daley CL, Small PM, Schecter GF, et al (1992) An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med 326: 231-235
18. Selwyn PA, Hartel D, Lewis VA, et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320: 545-550
19. Small PM, Shafer RW, Hopewell PC, et al (1993) Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 328: 1137-1144
20. Katz DJ, Hall WN, Keon NB, Crane LR (1993) HIV testing in patients with tuberculosis: physician response to national recommendations. Am Rev Respir Dis 147: 1283-1286
21. Asch SM, London AS, Barnes PF, Gelberg L (1997) Testing for human immunodeficiency virus infection among tuberculosis patients in Los Angeles. Am J Respir Crit Care Med 155: 378-381
22. Centers for Disease Control and Prevention (1994) Tuberculosis morbidity - United States. MMWR Morb Mortal Wkly Rep 44: 387-389
23. Centers for Disease Control and Prevention (1995) Tuberculosis morbidity - United States. MMWR Morb Mortal Wkly Rep 454: 365-370
24. Centers for Disease Control and Prevention (1996) Tuberculosis morbidity - United States. MMWR Morb Mortal Wkly Rep 46: 695-700
25. Centers for Disease Control and Prevention (1997) Tuberculosis morbidity - United States. MMWR Morb Mortal Wkly Rep 47: 253-257
26. Allen S, Batungwanayo J, Kerlikowske K, et al (1993) Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis 146: 1439-1444
27. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, et al (1992) High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 268: 504-509
28. Guelar A, Gatell JM, Verdejo J, et al (1993) A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 7: 1345-1349
29. Antonucci G, Girardi E, Raviglione MC, Ippolito G (1995) Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo italiano di Studio Tuberculosi e AIDS (GISTA) JAMA 274: 143-148
30. Dupon M, Texier-Maugein J, Leroy V, et al (1995) Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to anti-tuberculous drugs, Bordeau, 1985-1993. Groupe d'Épidemiologie Clinique du SIDA en Aquitaine. AIDS 9: 577-583
31. Snyder DC, Mohle-Boetani JC, Chandler A, Oliver J, et al (1997) A population-based study determining the incidence of tuberculosis attributable to HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 16: 190-194
32. Moore M, McCray E, Onorato IM (1997) The proportion of US TB cases with a match in the AIDS registry. Am J Respir Crit care Med 155: 23 [Abstract]
33. Onorato I, McCombs S, Morgan WM, McCray E (1993) HIV infection in patients attending tuberculosis clinics, United States, 1988-1992. Program and abstracts, 33rd International Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC, p 1363 [Abstract]
34. Telzak EE, Fazal BA, Pollard CL, Turett GS, et al (1997) Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis 25: 666-670
35. Ackah AN, Coulibaly D, Digbeu, et al (1995) Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet 345: 607-610
36. Bwire R, Borgdorff MW, Sticht-Groh HL, et al (1999) Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in SouthEastern Uganda. East Afr Med J 76: 307-313
37. Hawken M, Nunn P, Gathua S, et al (1993) Increased recurrence of tuberculosis in HIV-1 infected patients in Kenya. Lancet 342: 332-337
38. Sunderham G, McDonald RJ, Maniatis T, Oleske J, et al (1986) Tuberculosis as a manifestation of the acquired immunodeficiency syndrome. JAMA 256: 362-366
39. Louie E, Rice LB, Holzman RS (1986) Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome. Chest 90: 542-545
40. Nunn P, Brindle R, Carpenter L, et al (1992) Cohort study of human immunodeficiency virus infection in patients with tuberculosis, Nairobi, Kenya: analysis of early (6-month) mortality. Am Rev Respir Dis 146: 849-854
41. Rose R (1991) Immunology of the lung in HIV infection: the pathophysiologic basis for the development of tuberculosis in the AIDS setting. Bull Int Union Tuberc Lung Dis 66: 15-20
42. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis (1991) MMWR Morb Mortal Wkly Rep 40: 27-32